These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38216704)

  • 21. [Neurophysiology of corticobasal degeneration].
    Tyvaert L; Cassim F; Derambure P; Defebvre L
    Rev Neurol (Paris); 2007 Sep; 163(8-9):779-91. PubMed ID: 17878804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial tauopathy mimicking corticobasal degeneration an autopsy study on three siblings.
    Uchihara T; Nakayama H
    J Neurol Sci; 2006 Jul; 246(1-2):45-51. PubMed ID: 16540122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic interventions in parkinsonism: Corticobasal degeneration.
    Marsili L; Suppa A; Berardelli A; Colosimo C
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S96-100. PubMed ID: 26382843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
    Mori H; Nishimura M; Namba Y; Oda M
    Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases.
    Stamelou M; Alonso-Canovas A; Bhatia KP
    Mov Disord; 2012 May; 27(6):696-702. PubMed ID: 22550031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study.
    Boeve BF
    J Mol Neurosci; 2011 Nov; 45(3):350-3. PubMed ID: 21853287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases.
    Nishida N; Yoshida K; Hata Y; Arai Y; Kinoshita K
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):893-905. PubMed ID: 25708668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An autopsied case of corticobasal degeneration showing severe cerebral atrophy over a protracted disease course of 16 years.
    Kondo D; Hino H; Shibuya K; Fujisawa K; Kosaka K; Hirayasu Y; Yamamoto R; Kasanuki K; Minegishi M; Sato K; Hosokawa M; Arai T; Arai H; Iseki E
    Neuropathology; 2015 Jun; 35(3):280-8. PubMed ID: 25516199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An autopsy case of corticobasal degeneration clinically misdiagnosed as Pick's disease].
    Oda T; Ikeda K; Akamatsu W; Iwabuchi K; Akiyama H; Kondo H; Seta K; Kato Y; Kogure T; Hori K
    Seishin Shinkeigaku Zasshi; 1995; 97(9):757-69. PubMed ID: 8552729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes.
    Sakai K; Piao YS; Kikugawa K; Ohara S; Hasegawa M; Takano H; Fukase M; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2006 Sep; 112(3):341-8. PubMed ID: 16804710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression and anxiety in multiple sclerosis. Review of a fatal combination.
    Jellinger KA
    J Neural Transm (Vienna); 2024 Aug; 131(8):847-869. PubMed ID: 38869643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticobasal degeneration.
    Grijalvo-Perez AM; Litvan I
    Semin Neurol; 2014 Apr; 34(2):160-73. PubMed ID: 24963675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pallidal degenerations and related disorders: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jun; 129(5-6):521-543. PubMed ID: 34363531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical aspects of corticobasal syndrome].
    Shimohata T; Nishizawa M
    Brain Nerve; 2013 Jan; 65(1):31-40. PubMed ID: 23300101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathomechanisms of cognitive impairment in progressive supranuclear palsy.
    Jellinger KA
    J Neural Transm (Vienna); 2023 Apr; 130(4):481-493. PubMed ID: 36862189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancy between clinical and pathological diagnoses of CBD and PSP.
    Mizuno T; Shiga K; Nakata Y; Nagura J; Nakase T; Ueda Y; Takanashi Y; Urasaki K; Oyamada Y; Fushiki S; Nishikawa J; Yasuhara M; Nakajima K; Nakagawa M
    J Neurol; 2005 Jun; 252(6):687-97. PubMed ID: 15754090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.
    Dickson DW; Bergeron C; Chin SS; Duyckaerts C; Horoupian D; Ikeda K; Jellinger K; Lantos PL; Lippa CF; Mirra SS; Tabaton M; Vonsattel JP; Wakabayashi K; Litvan I;
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):935-46. PubMed ID: 12430710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symmetric corticobasal degeneration (S-CBD).
    Hassan A; Whitwell JL; Boeve BF; Jack CR; Parisi JE; Dickson DW; Josephs KA
    Parkinsonism Relat Disord; 2010 Mar; 16(3):208-14. PubMed ID: 20018548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome.
    Kouri N; Murray ME; Hassan A; Rademakers R; Uitti RJ; Boeve BF; Graff-Radford NR; Wszolek ZK; Litvan I; Josephs KA; Dickson DW
    Brain; 2011 Nov; 134(Pt 11):3264-75. PubMed ID: 21933807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.